ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · Real-Time Price · USD
2.490
+0.050 (2.05%)
At close: Aug 1, 2025, 4:00 PM
2.410
-0.080 (-3.21%)
After-hours: Aug 1, 2025, 7:59 PM EDT
CTI BioPharma Market Cap
ReShape Lifesciences has a market cap or net worth of $5.94 million as of August 1, 2025. Its market cap has decreased by -13.34% in one year.
Market Cap
5.94M
Enterprise Value
3.32M
1-Year Change
-13.34%
Ranking
Category
Stock Price
$2.49
Market Cap Chart
Since January 25, 2019, ReShape Lifesciences's market cap has increased from $2.57M to $5.94M, an increase of 131.40%. That is a compound annual growth rate of 13.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 5.94M | 86.91% |
| Dec 31, 2024 | 3.18M | -31.25% |
| Dec 29, 2023 | 4.62M | 42.07% |
| Dec 30, 2022 | 3.25M | -88.83% |
| Dec 31, 2021 | 29.13M | 46.99% |
| Dec 31, 2020 | 19.82M | 1,088.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.35B |
| Johnson & Johnson | 402.82B |
| AbbVie | 334.40B |
| UnitedHealth Group | 241.34B |
| AstraZeneca | 236.88B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.66B |
| Novo Nordisk | 221.96B |